XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements Of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Total
Balance, beginning of period at Dec. 31, 2021 $ 1,292,479 $ 411,072 $ (56,082) $ 1,647,469
Balance, beginning of period (in shares) at Dec. 31, 2021 151,124      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss   (42,031)   (42,031)
Foreign currency translation adjustments     (13,148) (13,148)
Activity in company stock plans, net and other $ (1,178)     (1,178)
Activity in company stock plans, net and other (in shares) 513      
Share-based compensation $ 1,634     1,634
Balance, end of period at Mar. 31, 2022 $ 1,292,935 369,041 (69,230) 1,592,746
Balance, end of period (in shares) at Mar. 31, 2022 151,637      
Balance, beginning of period at Dec. 31, 2022 $ 1,298,740 323,288 (105,319) 1,516,709
Balance, beginning of period (in shares) at Dec. 31, 2022 151,935      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss   (5,165)   (5,165)
Foreign currency translation adjustments     8,432 8,432
Repurchases of common stock $ (5,006)     (5,006)
Repurchases of common stock (in shares) (660)      
Activity in company stock plans, net and other $ (742)     (742)
Activity in company stock plans, net and other (in shares) 219      
Share-based compensation $ 1,492     1,492
Balance, end of period at Mar. 31, 2023 $ 1,294,484 $ 318,123 $ (96,887) $ 1,515,720
Balance, end of period (in shares) at Mar. 31, 2023 151,494